selected scholarly activity
-
conferences
- Estimating the Comparative Accuracy of Diagnostic Tests: AN Example using Typhoid Fever. Value in Health. A574-A575. 2017
- A META-EPIDEMIOLOGICAL SURVEY OF THE REPORTING OF EFFECT MODIFICATION IN NETWORK META-ANALYSES. Value in Health. A330-A330. 2017
- NETWORK META-ANALYSIS TO ASSESS THE RELATIVE EFFICACY AND SAFETY OF LINAGLIPTIN, EMPAGLIFLOZIN AND THE FIXED DOSE COMBINATION OF EMPAGLIFLOZIN AND LINAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM). Value in Health. A667-A667. 2016
- Increased risk of cardiovascular-related events associated with sulfonylureas compared to other antihyperglycaemic drugs: a Bayesian meta-analysis of survival data. Diabetologia. S64-S64. 2015
- Secukinumab 300 mg demonstrates highest probability of efficacy than other biologics in psoriasis: indirect comparison. Australasian Journal of Dermatology. 27-28. 2015
- Comparative Safety of Triptans, Non-Steroidal Anti-Inflammatory Drugs, and Ergotamines for the Acute Treatment of Migraine: A Network Meta-Analysis. Headache. 16-17. 2014
- Risk of Medication Overuse Headache Across Classes of Treatment for Migraine. Headache. 51-51. 2014
- Comparative efficacy and safety of golimumab, infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis: A bayesian indirect treatment comparison meta-analysis. Value in Health. A35-A35. 2014
- Cost-effectiveness of golimumab versus infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis. Value in Health. A38-A38. 2014
- Factors Associated With Large Increases in Self-Reported Health Status in Infliximab-Treated IBD Patients. Gastroenterology. S445-S445. 2014
- Factors associated with large increases in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from the bioadvance survey. Value in Health. A39-A40. 2014
- Comparative efficacy and safety of antidepressant use among elderly patients - a network meta-analysis. Journal of The American Geriatrics Society. S38-S39. 2014
- Adherence Interventions to Improve Adherence to Antiretroviral Therapy in Low Income Settings: An Individual Patient Data Network Meta-Analysis. Value in Health. A361-A361. 2013
- Easing Decision-Making by Expanding Methods of Multiple Treatment Comparison Meta-Analysis – Incorporating Non-Comparative Studies Via Informative Priors. Value in Health. A577-A577. 2013
- Adalimumab versus Infliximab for the Treatment of Moderate-to-severe Ulcerative Colitis in Adult Patients with No Prior Anti-TNF Experience: An Indirect Comparison Meta-analysis. American Journal of Gastroenterology. S543-S543. 2013
- FRI0431 Why the findings of published rheumatoid arthritis multiple treatment comparisons are so different – an overview of recurrent methodological shortcomings. Annals of the Rheumatic Diseases. 460.1-460. 2013
- Impact of multiple treatment comparison meta-analysis on value of information evaluations: a case study of pharmacotherapies for chronic obstructive pulmonary diseases. Value in Health. A26-A27. 2013
- Modelling drug class effects in bayesian multiple treatment comparison meta-analysis: Applications in early and advanced parkinson's disease. Value in Health. A26-A26. 2013
- The effects of excluding treatments from network meta-analysis. Value in Health. A51-A51. 2013
- Why are the findings of cost-effectiveness analyses of biologic treatment for rheumatoid arthritis so different?. Value in Health. A19-A19. 2013
- Why are the findings of indirect comparisons of boceprevir and telaprevir for hepatitis C infection different? A methodological review. Value in Health. A14-A14. 2013
- CL3 Calibrating Bayesian Multiple Treatment Comparison Meta-Analysis With Multiple Cost-Effectiveness Acceptability Curves. Value in Health. A286-A286. 2012
- PMS6 Anti-Tumour Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis (PsA). Value in Health. A440-A440. 2012
- PRM148 Sample Size and Power Considerations in Network Meta-Analysis. Value in Health. A487-A487. 2012
- PMS85 Why the Findings of Published Rheumatoid Arthritis Multiple Treatment Comparisons are So Different - An Overview of Recurrent Methodological Shortcomings. Value in Health. A49-A49. 2012
- PMS90 the Influence of ‘Weak Links' on Comparative Treatment Effects in Multiple Treatment Comparison Meta-Analysis: A Simulation Study. Value in Health. A50-A50. 2012
- PRS52 The Stability of Additive Treatment Effects in Multiple Treatment Comparison Meta-Analysis: a Simulation Study. Value in Health. A61-A61. 2012
- PSY65 Meta-Analysis of Health-Related Quality of Life Outcomes – Methods for Enhancing Interpretability of Findings. Value in Health. A110-A110. 2012
- 1141 BOCEPREVIR OR TELAPREVIR IN COMBINATION WITH PEGINTERFERON FOR HEPATITIS C GENOTYPE 1 INFECTION: AN INDIRECT COMPARISON META-REGRESSION ANALYSIS. Journal of Hepatology. S451-S451. 2012
- Comparative Efficacy of Triptans for the Abortive Treatment of Migraine: A Multiple Treatment Comparison Meta-Analysis (MTC). Annals of Neurology. S88-S89. 2012
- PEGINTERFERON ALPHA-2A MAY ACHIEVE HIGHER SUSTAINED VIROLOGICAL RESPONSE THAN PEGINTERFERON ALPHA-2B IN CHRONIC HEPATITIS C: A COCHRANE SYSTEMATIC REVIEW OF RANDOMIZED CLINICAL TRIALS. Hepatology. 707A-708A. 2009
- Effect of Perioperative Insulin Infusion on Surgical Morbidity and Mortality: Systematic Review and Meta-analysis of Randomized Trials. Mayo Clinic proceedings. 418-430. 2008
- 925 GLUCOCORTICOSTEROIDS FOR ALCOHOLIC HEPATITIS. Journal of Hepatology. S347-S347. 2008
-
journal articles
- Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial.. American Journal of Clinical Nutrition. 120:602-609. 2024
- The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States. Value in Health. 27:999-1002. 2024
- Matched vs Nonmatched Placebos in a Randomized Trial of COVID-19 Treatments. JAMA network open. 7:e2410335-e2410335. 2024
- Adapting Health Technology Assessment agency standards for surrogate outcomes in early stage cancer trials: what needs to happen?. Expert Review of Pharmacoeconomics and Outcomes Research. 24:331-342. 2024
- Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers. Journal of Comparative Effectiveness Research. 13:e230147. 2024
- The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials. Communications Medicine. 3:53. 2023
- Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model. American Journal of Tropical Medicine and Hygiene. 108:101-106. 2023
- Infliximab as a second‐line therapy for children with refractory Kawasaki disease: A systematic review and meta‐analysis of randomized controlled trials. British Journal of Clinical Pharmacology. 89:49-60. 2023
- A Bayesian adaptive design for clinical trials of rare efficacy outcomes with multiple definitions. Clinical Trials. 19:613-622. 2022
- Effects of the mediterranean diet versus low-fat diet on metabolic syndrome outcomes: A systematic review and meta-analysis of randomized controlled trials. Journal of Nutrition & Intermediary Metabolism. 30:200175-200175. 2022
- The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment. Value in Health. 25:1253-1256. 2022
- Fluvoxamine for the Early Treatment of COVID-19: A Meta-analysis of Randomized Clinical Trials. American Journal of Tropical Medicine and Hygiene. 106:1315-1320. 2022
- Making Statistical Sense of the Molnupiravir MOVe-OUT Clinical Trial. American Journal of Tropical Medicine and Hygiene. 106:1301-1304. 2022
- Molnupiravir for Covid-19 in Nonhospitalized Patients. New England Journal of Medicine. 386:e32. 2022
- Protocol for a sequential, prospective meta-analysis to describe coronavirus disease 2019 (COVID-19) in the pregnancy and postpartum periods. PLoS ONE. 17:e0270150-e0270150. 2022
- Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART. BMC Medical Research Methodology. 21:60. 2021
- When does the use of individual patient data in network meta-analysis make a difference? A simulation study. BMC Medical Research Methodology. 21:21. 2021
- Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non–Small Cell Lung Cancer. JAMA network open. 4:e2134299-e2134299. 2021
- Assessment of Alectinib vs Ceritinib in ALK-Positive Non–Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data. JAMA network open. 4:e2126306-e2126306. 2021
- Corrigendum to GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 2011;64:1283–1293. Journal of Clinical Epidemiology. 137:265-265. 2021
- Randomised trials at the level of the individual. The Lancet Global Health. 9:e691-e700. 2021
- The role and challenges of cluster randomised trials for global health. The Lancet Global Health. 9:e701-e710. 2021
- Utilizing Bayesian predictive power in clinical trial design. Pharmaceutical Statistics. 20:256-271. 2021
- Reporting and design of randomized controlled trials for COVID-19: A systematic review. Contemporary Clinical Trials. 101:106239-106239. 2021
- Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis. EClinicalMedicine. 28:100573-100573. 2020
- An overview of platform trials with a checklist for clinical readers. Journal of Clinical Epidemiology. 125:1-8. 2020
- Prevalence and incidence of HIV among female sex workers and their clients: modelling the potential effects of intervention in Rwanda. BMJ Global Health. 5:e002300-e002300. 2020
- A real-time dashboard of clinical trials for COVID-19. The Lancet Digital Health. 2:e286-e287. 2020
- Association Between Myocardial Injury and Cardiovascular Outcomes of Orthopaedic Surgery. Journal of Bone and Joint Surgery. American volume. 102:880-888. 2020
- Sequential Monte Carlo for response adaptive randomized trials. Biostatistics. 21:287-301. 2020
- An overview of precision oncology basket and umbrella trials for clinicians. CA - A Cancer Journal for Clinicians. 70:125-137. 2020
- An Exploratory Analysis of Predictors of Concordance Between Canadian Common Drug Review Reimbursement Recommendations and the Subsequent Decisions by Ontario, British Columbia and Alberta. Healthcare Policy. 15:90-101. 2020
- <p>Synthetic and External Controls in Clinical Trials – A Primer for Researchers</p>. Clinical Epidemiology. Volume 12:457-467. 2020
- Minimizing control group allocation in randomized trials using dynamic borrowing of external control data – An application to second line therapy for non-small cell lung cancer. Contemporary Clinical Trials Communications. 16:100446-100446. 2019
- Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols. Trials. 20:572. 2019
- Effects of biomarker diagnostic accuracy on biomarker-guided phase 2 trials. Contemporary Clinical Trials Communications. 15:100396-100396. 2019
- Reporting of master protocols towards a standardized approach: A systematic review. Contemporary Clinical Trials Communications. 15:100406-100406. 2019
- Association of Early Interventions With Birth Outcomes and Child Linear Growth in Low-Income and Middle-Income Countries. JAMA network open. 2:e197871-e197871. 2019
- Comparative accuracy of typhoid diagnostic tools: A Bayesian latent-class network analysis. PLoS Neglected Tropical Diseases. 13:e0007303-e0007303. 2019
- Highly Efficient Clinical Trials Simulator (HECT): Software application for planning and simulating platform adaptive trials. Gates Open Research. 3:780-780. 2019
- Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis. Gates Open Research. 3:1657-1657. 2019
- Interventions to improve linear growth during complementary feeding period for children aged 6-24 months living in low- and middle-income countries: a systematic review and network meta-analysis. Gates Open Research. 3:1660-1660. 2019
- Interventions to improve linear growth during exclusive breastfeeding life-stage for children aged 0-6 months living in low- and middle-income countries: a systematic review with network and pairwise meta-analyses. Gates Open Research. 3:1720-1720. 2019
- Key design considerations for adaptive clinical trials: a primer for clinicians. The BMJ. 360:k698-k698. 2018
- Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis. Schizophrenia Research and Treatment. 2018:1-9. 2018
- Critical concepts in adaptive clinical trials. Clinical Epidemiology. Volume 10:343-351. 2018
- Bayesian adaptive clinical trials of combination treatments. Contemporary Clinical Trials Communications. 8:227-233. 2017
- Landscape review of current HIV ‘kick and kill’ cure research - some kicking, not enough killing. BMC Infectious Diseases. 17:595. 2017
- Comparative tolerability of treatments for acute migraine: A network meta-analysis. Cephalalgia. 37:965-978. 2017
- Deficiencies in addressing effect modification in network meta-analyses: a meta-epidemiological survey. Journal of Clinical Epidemiology. 88:47-56. 2017
- Comparison of the Adverse Event Profile of TheraSphere® with SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review. CardioVascular and Interventional Radiology. 40:1033-1043. 2017
-
Cardiovascular events and all‐cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs:
A B ayesian meta‐analysis of survival data. Diabetes, Obesity and Metabolism. 19:329-335. 2017 - Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes. Clinical Epidemiology. Volume 9:291-296. 2017
- Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. The Lancet HIV. 4:e31-e40. 2017
- Interpreting trial sequential analysis. Transfusion. 56:2918-2922. 2016
- Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review. BMC Pediatrics. 16:181. 2016
- Risk of medication overuse headache across classes of treatments for acute migraine. Journal of Headache and Pain. 17:107. 2016
- Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis. The Lancet HIV. 3:e510-e520. 2016
- Use of network meta-analysis in clinical guidelines. Bulletin of the World Health Organization. 94:782-784. 2016
- False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review. BMJ Open. 6:e011890-e011890. 2016
- Comparative efficacy and safety of estradiol transdermal preparations for the treatment of vasomotor symptoms in postmenopausal women. Menopause. 23:294-303. 2016
- Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer. Annals of Surgery. 263:345-352. 2016
- Use of peers to improve adherence to antiretroviral therapy: a global network meta‐analysis. Journal of the International AIDS Society. 19:21141. 2016
- Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis. Oncotarget. 6:35564-35578. 2015
- Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing. Current Medical Research and Opinion. 31:2031-2042. 2015
- Are current standards of reporting quality for clinical trials sufficient in addressing important sources of bias?. Contemporary Clinical Trials. 45:2-7. 2015
- Heterogeneity in the Definition of Drug Induced Hypoglycemia in Clinical Trials: A Review. Value in Health. 18:A601-A601. 2015
- Non-Comparative Trials To Supplement Network Meta-Analyses Using Arm-Specific Meta-Regression: An Application To Combination Therapies In Hiv. Value in Health. 18:A683-A684. 2015
- The Use of Single-Arm Evidence In The Comparative Efficacy of Interferon-Free Antivirals for Treatment-Naïve Hepatitis C Genotype 1. Value in Health. 18:A576-A576. 2015
- Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study. The Lancet HIV. 2:e376-e384. 2015
- Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey. Expert Review of Gastroenterology and Hepatology. 9:1015-1021. 2015
- Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis. Journal of Medical Economics. 18:437-446. 2015
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations. ACP journal club. 162:777-784. 2015
- Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs. Expert Review of Gastroenterology and Hepatology. 9:693-700. 2015
- Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin‐Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta‐Analysis. Journal of The American Geriatrics Society. 63:1002-1009. 2015
- Combination Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Whom, When, and Where?. Open Forum Infectious Diseases. 2:ofv071. 2015
- Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection. QJM - Monthly Journal of the Association of Physicians. 108:299-306. 2015
- Ethical Testing of Experimental Ebola Treatments. Journal of the American Medical Association (JAMA). 313:421-421. 2015
- Ethical Testing of Experimental Ebola Treatments—Reply. Journal of the American Medical Association (JAMA). 313:422-422. 2015
- Completeness of main outcomes across randomized trials in entire discipline: survey of chronic lung disease outcomes in preterm infants. The BMJ. 350:h72-h72. 2015
- Comparative Effectiveness of Induction Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: A Network Meta-Analysis. Open Forum Infectious Diseases. 2:ofv010. 2015
- Erratum to" GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles–continuous outcomes"[J Clin Epidemiol 2013; 66 (2): 173-183]. Journal of Clinical Epidemiology. 68:475-475. 2015
- Incorporating alternative design clinical trials in network meta-analyses. Clinical Epidemiology. 7:29-29. 2015
- Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysis. The Lancet HIV. 1:e104-e111. 2014
- The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis. Systematic Reviews. 3:116. 2014
- Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin. Value in Health. 17:A332-A333. 2014
- Comparative Efficacy and Safety of Empagliflozin with Other Antidiabetic Drugs for the Third Line Treatment of Type 2 Diabetes Mellitus. Value in Health. 17:A333-A333. 2014
- Comparative Efficacy and Safety of Empagliflozin with Other Oral Antidiabetic Drugs for the Second Line Treatment of Type 2 Diabetes Mellitus. Value in Health. 17:A333-A333. 2014
- Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes. PharmacoEconomics (Auckland). 32:995-1004. 2014
- Reanalyses of Randomized Clinical Trial Data. Journal of the American Medical Association (JAMA). 312:1024-1024. 2014
- Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults. Journal of the American Medical Association (JAMA). 312:923-923. 2014
- Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis. Journal of Crohn's and Colitis. 8:571-581. 2014
- Letter to the Editor. Journal of Medical Economics. 17:445-445. 2014
- The architecture of diagnostic research: From bench to bedside-research guidelines using liver stiffness as an example. Hepatology. 60:408-418. 2014
- What drives the comparative effectiveness of biologics vs methotrexate in rheumatoid arthritis? Meta-regression and graphical inspection of suspected clinical factors. Rheumatology. 53:1264-1273. 2014
- What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women. European Urology. 65:1211-1217. 2014
- Comparative efficacy of triptans for the abortive treatment of migraine: A multiple treatment comparison meta-analysis. Cephalalgia. 34:258-267. 2014
- A users' guide to understanding therapeutic substitutions. Journal of Clinical Epidemiology. 67:305-313. 2014
- Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta-analysis and trial sequential analysis. British Journal of Anaesthesia. 112:410-426. 2014
- Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C. Cochrane Database of Systematic Reviews. 2014:CD005642. 2014
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C. Cochrane Database of Systematic Reviews. 2014:CD005441. 2014
- Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analyses. Clinical Microbiology and Infection (CMI). 20:114-122. 2014
- Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies. Circulation. 129:28-41. 2014
- Nonergot dopamine-receptor agonists for treating Parkinson's disease – a network meta-analysis. Neuropsychiatric Disease and Treatment. 10:767-767. 2014
- SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin. Clinical Epidemiology. 6:49-49. 2014
- The Quality of Reporting Methods and Results in Network Meta-Analyses: An Overview of Reviews and Suggestions for Improvement. PLoS ONE. 9:e92508-e92508. 2014
- The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD. Cost Effectiveness and Resource Allocation. 12:8-8. 2014
- Comparative effectiveness of monotherapies and combination therapies for patients with hypertension: protocol for a systematic review with network meta-analyses. Systematic Reviews. 2:44. 2013
- Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution?. BMC Medical Research Methodology. 13:2. 2013
- Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol. Systematic Reviews. 2:18. 2013
- Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales. Nature Reviews Rheumatology. 9:665-673. 2013
- The effects of excluding treatments from network meta-analyses: survey. The BMJ. 347:f5195-f5195. 2013
- Random error in cardiovascular meta-analyses: How common are false positive and false negative results?. International Journal of Cardiology. 168:1102-1107. 2013
- Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings. Annals of the Rheumatic Diseases. 72:1524-1535. 2013
- Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews. 34:CD006095. 2013
- Demystifying trial networks and network meta-analysis. The BMJ. 346:f2914-f2914. 2013
- Central statistical monitoring: Detecting fraud in clinical trials. Clinical Trials. 10:225-235. 2013
- Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 56:961-967. 2013
- Impact of Obesity on Urinary Storage Symptoms: Results from the FINNO Study. Investigative Urology. 189:1377-1382. 2013
- Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis. QJM - Monthly Journal of the Association of Physicians. 106:153-163. 2013
- Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa. AIDS. 27:417-425. 2013
- GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles—continuous outcomes. Journal of Clinical Epidemiology. 66:173-183. 2013
- Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design. Trials. 14:335-335. 2013
- Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection. Clinical Epidemiology. 5:173-173. 2013
- Longitudinal Measurements of Oxygen Consumption in Growing Infants during the First Weeks after Birth: Old Data Revisited. Neonatology. 103:224-232. 2013
- Patient-reported outcomes in meta-analyses --Part 2: methods for improving interpretability for decision-makers. Health and Quality of Life Outcomes. 11:211-211. 2013
- Probiotics for the Prevention ofClostridium difficile–Associated Diarrhea. ACP journal club. 157:878-878. 2012
- Calculating additive treatment effects from multiple randomized trials provides useful estimates of combination therapies. Journal of Clinical Epidemiology. 65:1282-1288. 2012
- Sample size and power considerations in network meta-analysis. Systematic Reviews. 1:41. 2012
- Conclusive meta‐analyses on antenatal magnesium may be inconclusive! Are we underestimating the risk of random error?. Acta Obstetricia et Gynecologica Scandinavica. 91:1247-1251. 2012
- How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis. Journal of the American Medical Association (JAMA). 308:1246-1246. 2012
- Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis. Annals of Medicine. 44:588-597. 2012
- New methods can extend the use of minimal important difference units in meta-analyses of continuous outcome measures. Journal of Clinical Epidemiology. 65:817-826. 2012
- Error in Viewpoint in: Statin Therapy for Healthy Men Identified as ‘Increased Risk,’. Journal of the American Medical Association (JAMA). 307:2590-2590. 2012
- Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. Journal of the American Medical Association (JAMA). 307:2295-2295. 2012
- The Use of Transcutaneous Oximetry to Predict Healing Complications of Lower Limb Amputations: A Systematic Review and Meta-analysis. European Journal of Vascular and Endovascular Surgery. 43:329-336. 2012
- Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis. Biologics: Targets and Therapy. 6:417-417. 2012
- Assessment and Implication of Prognostic Imbalance in Randomized Controlled Trials with a Binary Outcome – A Simulation Study. PLoS ONE. 7:e36677-e36677. 2012
- Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis. Therapeutics and Clinical Risk Management. 8:105-105. 2012
- Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection. ClinicoEconomics and Outcomes Research. 4:349-349. 2012
- Evolution of Heterogeneity (I2) Estimates and Their 95% Confidence Intervals in Large Meta-Analyses. PLoS ONE. 7:e39471-e39471. 2012
- Molecular Detection of Tumor Cells in Regional Lymph Nodes Is Associated With Disease Recurrence and Poor Survival in Node-Negative Colorectal Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. 30:60-70. 2012
- Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. ACP journal club. 156:710-719. 2012
- Stability of additive treatment effects in multiple treatment comparison meta-analysis: a simulation study. Clinical Epidemiology. 4:75-75. 2012
- Comparison of statistical inferences from the DerSimonian–Laird and alternative random‐effects model meta‐analyses – an empirical assessment of 920 Cochrane primary outcome meta‐analyses. Research Synthesis Methods. 2:238-253. 2011
- GRADE guidelines 6. Rating the quality of evidence—imprecision. Journal of Clinical Epidemiology. 64:1283-1293. 2011
- Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infectious Diseases. 11:134. 2011
- The use of transcutaneous oximetry to predict complications of chronic wound healing: A systematic review and meta‐analysis. Wound Repair and Regeneration. 19:657-663. 2011
- Pooling health‐related quality of life outcomes in meta‐analysis—a tutorial and review of methods for enhancing interpretability. Research Synthesis Methods. 2:188-203. 2011
- Hepato‐biliary clinical trials and their inclusion in the Cochrane Hepato‐Biliary Group register and reviews. Journal of Gastroenterology and Hepatology. 26:649-656. 2011
- Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis. American Journal of Kidney Diseases. 57:566-574. 2011
- Reply:. Hepatology. 53:1407-1407. 2011
- Estimating the Power of Indirect Comparisons: A Simulation Study. PLoS ONE. 6:e16237-e16237. 2011
- An international prospective cohort study evaluating major vascular complications among patients undergoing noncardiac surgery: the VISION Pilot Study.. Open Medicine. 5:e193-e200. 2011
- GRADE guidelines: 6. Rating the quality of evidence-imprecision. Chinese Journal of Evidence-Based Medicine. 11:1435-1443. 2011
- Multiple treatment comparison meta-analyses: a step forward into complexity. Clinical Epidemiology. 3:193-193. 2011
- The Number of Patients and Events Required to Limit the Risk of Overestimation of Intervention Effects in Meta-Analysis—A Simulation Study. PLoS ONE. 6:e25491-e25491. 2011
- Comments on ‘Sequential meta-analysis: an efficient decision-making tool’ by I van der Tweel and C Bollen. Clinical Trials. 7:752-753. 2010
- Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health and Quality of Life Outcomes. 8:116. 2010
- Reply:. Hepatology. 52:2241-2241. 2010
- Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology. 2:57-57. 2010
- Reply: Methodological issues in a meta-analysis. Hepatology. 52:396-397. 2010
- Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer. Gastroenterology. 138:1714-1726.e13. 2010
- Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials. Hepatology. 51:1176-1184. 2010
- Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology. 9:86. 2009
- Cryotherapy for hepatocellular carcinoma. Cochrane Database of Systematic Reviews. CD007611. 2009
- Pegylated interferon alpha 2a for chronic hepatitis C. Cochrane Database of Systematic Reviews. 2009
- Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for chronic hepatitis C. Clinical Respiratory Journal. 2009
- Probiotics for the prevention of Clostridium difficile associated diarrhea in adults and children. Clinical Respiratory Journal. 2009
- Glucocorticoids can help in acute severe alcoholic hepatitis: authors’ reply. Alimentary Pharmacology and Therapeutics. 30:93-95. 2009
- Hepatitis C intervention research – Where are we now and where should we be heading?. Arab Journal of Gastroenterology. 10:4-9. 2009
- Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology. 38:287-298. 2009
- Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?. International Journal of Epidemiology. 38:276-286. 2009
- Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. European Heart Journal. 29:2592-2600. 2008
- Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-analyses. ACP journal club. 149:596-596. 2008
- Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses (Annals of Internal Medicine (2008) 149, (219)). Annals of Internal Medicine. 149:596. 2008
- Attention should be given to multiplicity issues in systematic reviews. Journal of Clinical Epidemiology. 61:857-865. 2008
- Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses. ACP journal club. 149:219-219. 2008
- Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology. 61:763-769. 2008
- Systematic review: glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato‐Biliary Group systematic review with meta‐analyses and trial sequential analyses of randomized clinical trials. Alimentary Pharmacology and Therapeutics. 27:1167-1178. 2008
- Hypothermia: An Evolving Treatment for Neonatal Hypoxic Ischemic Encephalopathy: In Reply. Pediatrics. 121:649-650. 2008
- Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology. 61:64-75. 2008
- Cooling for Neonatal Hypoxic Ischemic Encephalopathy: Do We Have the Answer?. Pediatrics. 120:1126-1130. 2007